I joined the Ludwig Institute in July 2022 as the Deputy Scientific Director. In this role, I support the Scientific Director in overseeing and supporting the research efforts across the Ludwig Cancer Research community. I received my Bachelor’s and Master’s degrees in biophysics from University of Quebec, Canada, before moving to Boston, where I obtained my PhD in molecular biology from Boston University. I conducted my postdoctoral training at what is currently the Ludwig Center at Johns Hopkins in the laboratory of Bert Vogelstein and Ken Kinzler, where I studied the molecular genetics of colorectal cancer. During that time, we identified, for the first time, beta-catenin mutations in colorectal cancer. In 1998, I joined the intramural program of the NIH as an investigator to lead a research laboratory focused on ovarian cancer. While at NIH, I also held an Adjunct Assistant Professor position at the Johns Hopkins School of Medicine, Department of Pathology. In 2012, I left NIH to join the American Association for Cancer Research as the Senior Director of Scientific Review and Grants Administration, where I oversaw the selection, administration and oversight of a large grant and award portfolio, including the Stand Up To Cancer Programs. More recently, I was Executive Director of strategic alliances at the Abramson Cancer Center, University of Pennsylvania, where I helped foster new collaborations with various pharmaceutical and biotech companies for drug development.
Click here to read a Q&A with Pat Morin.